AMDCP Credit Designation: This session has been approved for a total of 3 Clinical credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).
The American Medical Directors Association designates this educational activity fora maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Presenter(s): Steven A. Levenson, MD, CMD;Dana Saffel, PharmD; Jeffrey M. Behrens, MD, CMD Disclosure(s): JeffreyM. Behrens, MD, CMD is a medical director at Vitas HealthCare. DanaSaffel, PharmD received consultant honoraria from Eli Lilly and Company, ForestPharmaceuticals, Inc., and GlaxoSmithKline. StevenA. Levenson, MD, CMD has no relevant financial relationships to disclose. Session Description: This session presents a comprehensive practical approach tothe management of nursing facility residents and patients with problematicbehavior and changes in mental function. It is geared towards optimizing therole of the primary care practitioner, and the processes and approaches neededto manage these complex patients and challenging situations. Learning Objectives:
Review and discuss effective approaches to analyzing and managingchanges in mental function and problematic behavior in residents andpatients in nursing facilities
Identify key areas for collaboration between physicians, facility staff, and the consultant pharmacist related to effective management of altered mental function, behavior, and the use of psychopharmacological medications
Interpret regulatory requirements related to prescribing, monitoringand modifying psychopharmacological medications
References: AMDA Delirium and Acute Problematic Behavior Clinical Practice Guideline (2008 update). Columbia MD, 2008. CMS State Operations Manual, F329, Unnecessary Drugs survey or guidance